About: Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2011 (uk) article scientifique publié en 2011 (fr) im November 2011 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59007859-3CED14F9-01F1-4659-AF8A-4572593DF5B0
publication date	2011-04-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59007859-1F3B46EE-99E4-46C1-90CE-DB528E353C4E
language of work or name	English
author name string	wds:Q59007859-1A6EFCB6-56AA-4961-ACAB-123D82634D0D wds:Q59007859-3354B44C-6C4C-4C22-941F-5CB975C368D4 wds:Q59007859-8352CB5B-92B1-4F02-AB7F-9BB19BF063B1 wds:Q59007859-C6951BBC-A49F-4BD9-A89F-F82442DBEF30 wds:Q59007859-CEB9EB08-7935-4FD6-804C-2BDAB7A4A447 wds:Q59007859-E53C3DCF-C947-4239-8AB8-6E8BD692C639
author name string	Charles Catton Cynthia Ménard Danny Vesprini Gina Lockwood Andrew Bayley Michael Sia
rdfs:label	Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (en) Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (nl)
skos:prefLabel	Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (en) Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (nl)
name	Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (en) Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy (nl)
author	wds:Q59007859-06AFFE4C-27DD-48B5-8DBD-5A44C7F8771F wds:Q59007859-4E162B68-8137-4ACF-B32C-A5F436832D91 wds:Q59007859-92EA524F-AAF6-4311-ADD2-A7B1FB7346E7 wds:Q59007859-99584BE6-9D45-4FCF-8193-6CE4043C3E4E wds:Q59007859-B4B13693-EC4C-432D-9E7B-5B65FBAEE97C wds:Q59007859-E6DD0188-D99E-4E0E-B9A7-BAEBC4958CF4
author	Tara Rosewall Douglas Moseley Padraig Warde Robert G. Bristow Michael Milosevic Peter W Chung
title	wds:Q59007859-F370D3D9-5F70-4AE5-9A14-69C6AB82BE97
title	Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy (en)
page(s)	wds:Q59007859-DD6A57CD-6151-4A9A-8657-247259B81638
page(s)	e415-21
instance of	wds:Q59007859-F257559B-5CCD-4276-AF8A-DE85DA00F2A5
instance of	scholarly article
main subject	wds:Q59007859-085CE6DC-6B75-4E0C-AED7-C05E32CF2DE3 wds:Q59007859-3D9938D5-8FFE-4E19-ACE6-86E09FDB33A9
main subject	prostate cancer principal component analysis
PubMed ID	wds:Q59007859-16AE568D-8DDA-4CAD-8C2A-D7200C075ACA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21477939
PubMed ID	21477939
published in	wds:Q59007859-50CFEB45-4D6D-43D4-A690-10906DE75787
published in	International Journal of Radiation Oncology Biology Physics
issue	wds:Q59007859-6EED6BC3-EA2A-4D48-B20B-95325974120A
volume	wds:Q59007859-0B8DF3DA-0A9F-476D-9250-781DAAC1590E
issue	4
volume	81
DOI	wds:Q59007859-23721749-5831-409B-8D64-208E331073A1
DOI	http://dx.doi.org/10.1016/J.IJROBP.2011.01.024
DOI	10.1016/J.IJROBP.2011.01.024
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59007859
is cites work of	Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response. Late complications after radiotherapy for prostate cancer Late toxicity rates following definitive radiotherapy for prostate cancer. Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer. Refinement & validation of rectal wall dose volume objectives for prostate hypofractionation in 20 fractions
is cites work of	wds:Q42165844-9D8B53A7-34C7-4C79-B77A-6A8B37110E99 wds:Q87423470-112A17A6-BB13-416A-9CFF-DD2F15E7B9F5 wds:Q28559812-12C3917D-C881-4B1A-A663-49B1C9DEC8D9 wds:Q31139488-CD1F3D07-11F0-499E-8564-C8F5067E9535 wds:Q37256972-7A987ADC-6493-45FE-975F-702B28FC3CFA wds:Q38620687-D49D96A5-F5AB-449F-A8AE-87CBCD9DCE6F wds:Q36184227-D3D8D30E-CE2A-4A24-AAF8-717EB69C7A42 wds:Q89769931-D37A13BC-1ECE-44CC-A5E9-BD61A4B39FDA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software